Financial results - DRALEX NEUROLOGIE S.R.L.

Financial Summary - Dralex Neurologie S.r.l.
Unique identification code: 42509167
Registration number: J26/532/2020
Nace: 8622
Sales - Ron
19.539
Net Profit - Ron
-682
Employees
1
Open Account
Company Dralex Neurologie S.r.l. with Fiscal Code 42509167 recorded a turnover of 2024 of 19.539, with a net profit of -682 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Dralex Neurologie S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 8.829 23.248 21.294 21.588 19.539
Total Income - EUR - - - - - 8.829 23.248 21.294 21.588 19.539
Total Expenses - EUR - - - - - 361 688 1.671 16.637 19.646
Gross Profit/Loss - EUR - - - - - 8.469 22.561 19.623 4.951 -107
Net Profit/Loss - EUR - - - - - 8.204 21.877 19.088 4.768 -682
Employees - - - - - 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -9.0%, from 21.588 euro in the year 2023, to 19.539 euro in 2024. The Net Profit decreased by -4.741 euro, from 4.768 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Dralex Neurologie S.r.l.

Rating financiar

Financial Rating -
DRALEX NEUROLOGIE S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Dralex Neurologie S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dralex Neurologie S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Dralex Neurologie S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dralex Neurologie S.r.l. - CUI 42509167

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 94 0 0 21.657 14.863
Current Assets - - - - - 8.297 22.066 30.588 2.715 993
Inventories - - - - - 0 0 0 0 0
Receivables - - - - - 1.378 1.854 16.082 1.227 386
Cash - - - - - 6.919 20.212 14.506 1.488 607
Shareholders Funds - - - - - 8.245 21.926 19.137 8.676 4.107
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 146 140 11.451 15.696 11.784
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 993 euro in 2024 which includes Inventories of 0 euro, Receivables of 386 euro and cash availability of 607 euro.
The company's Equity was valued at 4.107 euro, while total Liabilities amounted to 11.784 euro. Equity decreased by -4.520 euro, from 8.676 euro in 2023, to 4.107 in 2024.

Risk Reports Prices

Reviews - Dralex Neurologie S.r.l.

Comments - Dralex Neurologie S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.